@prefix dc: <http://purl.org/dc/terms/> .
@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAmnuEh8ikDJRo3qtoSP7jkjk1ZtH87vcM6Hw2_0pCXLA> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAmnuEh8ikDJRo3qtoSP7jkjk1ZtH87vcM6Hw2_0pCXLA#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/small_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix schem: <http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/> .
@prefix hasPart: <http://purl.obolibrary.org/obo/BFO_0000051> .
@prefix mesh: <http://purl.bioontology.org/ontology/MSH/> .
@prefix do: <http://disease-ontology.org/term/DOID:> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix hasAnnotation: <http://semanticscience.org/resource/SIO_000255> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:_1 hasPart: schem:SU%205416, schem:SU%206668 .
  
  sub:_2 occursIn: do:162, mesh:D001808, obo:CL_0000669, species:10090;
    hasAnnotation: sub:_3;
    rdf:object mesh:D015687;
    rdf:predicate belv:increases;
    rdf:subject sub:_1;
    a rdf:Statement .
  
  sub:_3 dc:subject "TextLocation";
    rdf:value "Abstract" .
  
  sub:assertion rdfs:label "composite(a(SCHEM:\"SU 5416\"),a(SCHEM:\"SU 6668\")) -> bp(MESHPP:\"Cell Hypoxia\")" .
}

sub:provenance {
  beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved.";
    dce:title "BEL Framework Small Corpus Document";
    dc:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License";
    pav:authoredBy sub:_5;
    pav:version "20131211" .
  
  sub:_4 prov:value """targeting VEGFR-2 plus the platelet- derived growth factor receptor (PDGFR)-β system
(PDGFR- β) signaling (by SU6668) rapidly forced 40% of tumor blood vessels into
regression, rendering these tumors hypoxic as shown by phosphorescence quenching.""";
    prov:wasQuotedFrom pubmed:14657001 .
  
  sub:_5 rdfs:comment "support@belframework.org";
    rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource pubmed:14657001;
    prov:wasDerivedFrom beldoc:, sub:_4 .
}

sub:pubinfo {
  this: dc:created "2014-07-03T14:31:17.016+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}